Related Experiment Video

Updated: Dec 30, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

4.1K

Genome Editing for the Understanding and Treatment of Inherited Cardiomyopathies

Quynh Nguyen1, Kenji Rowel Q Lim1, Toshifumi Yokota1,2

  • 1Department of Medical Genetics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB T6G2H7, Canada.

International Journal of Molecular Sciences
|January 26, 2020
PubMed

Insights

Genome editing technologies like CRISPR offer new ways to understand and treat genetic cardiomyopathies, a serious heart muscle disease. This review explores current applications and future potential for these powerful genetic tools.

Area of Science:

  • Cardiovascular Medicine
  • Genetics
  • Molecular Biology

Background:

  • Cardiomyopathies are heart muscle diseases, often genetic, with significant global health impact.
  • Classifications include dilated, hypertrophic, restrictive, and arrhythmogenic types, with some linked to neuromuscular disorders.
  • Existing research highlights the need for novel therapeutic strategies.

Purpose of the Study:

  • To review the applications of genome editing technologies in understanding cardiomyopathy.
  • To discuss the potential of genome editing for treating various forms of cardiomyopathy.
  • To explore recent advancements and future prospects of genome editing in cardiovascular medicine.

Main Methods:

  • Review of current scientific literature on genome editing and cardiomyopathy.
  • Analysis of established and emerging genome editing tools (ZFNs, TALENs, CRISPR).
  • Discussion of case studies and experimental models applying genome editing to cardiomyopathies.

Main Results:

  • Genome editing tools are crucial for studying genetic cardiomyopathies.
  • CRISPR, ZFNs, and TALENs show promise in preclinical research for cardiomyopathy.
  • Advancements in genome editing are improving precision and efficiency for cardiovascular applications.

Conclusions:

  • Genome editing holds significant potential for advancing cardiomyopathy research.
  • These technologies offer novel therapeutic avenues for genetic heart muscle diseases.
  • Continued development of genome editing will likely revolutionize cardiomyopathy treatment.

Keywords:
CRISPR/Cas9Cpf1 (Cas12a)Duchenne muscular dystrophyarrhythmogenic right ventricular cardiomyopathy (ARVC)dilated cardiomyopathy (DCM)dystrophingenome editinghypertrophic cardiomyopathy (HCM)left ventricular non-compaction cardiomyopathy (LVNC)restrictive cardiomyopathy (RCM)

More Related Videos

CRISPR-Cas9-Mediated Precise Knock-In Edits in Zebrafish Hearts06:52

CRISPR-Cas9-Mediated Precise Knock-In Edits in Zebrafish Hearts

Published on: September 13, 2022

3.9K
Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice09:00

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice

Published on: August 2, 2018

8.5K

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
427
CRISPR01:59

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
57.3K
Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
8.9K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
307
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
385
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
380